$19.08
1.5%
Price vs. AI Score (Last 150 days)
Data gathered: December 6
Data gathered: December 6
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | 4 0% |
|
| Sentiment | 100 0% |
|
| Webpage traffic | 14,000 84.5% |
|
| Employee Rating | 68 0% |
|
| Google Adspend | $4,529 -56.8% | N/A |
| Google Trends | -100% |
|
| Linkedin Employees | 98 N/A |
|
| Patents | 9 0% |
|
| 4chan Mentions | 0% | N/A |
| Facebook Engagement | 100 -1% |
|
| Facebook followers | 145 0% |
|
| Stocktwits Mentions | 24 -54.7% |
|
| Stocktwits Subscribers | 684 1.3% |
|
| Twitter Followers | 13,209 -0% |
|
| Youtube Subscribers | 58 1.8% |
|
| Instagram Followers | 5,245 -0.1% |
|
| News Mentions | 0% |
|
| Reddit Mentions | -100% |
|
| Business outlook | 65 0% |
|
In the news
 |
Biomea Fusion Announces Health Canada Clearance of Clinical Trial Application (CTA) for BMF-219 in Type 1 DiabetesDecember 4 - Yahoo |
Biomea Fusion announces Health Canada Clearance of CTA for BMF-219December 4 - Thefly.com |
|
12 Health Care Stocks Moving In Monday's Intraday SessionDecember 3 - Benzinga |
|
SAIC Reports Q3 Results, Joins Uber, Wallbox And Other Big Stocks Moving Higher On MondayDecember 3 - Benzinga |
|
Citi opens 'positive catalyst watch' on Biomea Fusion into dataDecember 2 - Thefly.com |
|
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV) and Biomea Fusion (BMEA)December 2 - TipRanks |
|
About Biomea Fusion
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases.
| Price | $19.08 |
| Target Price | Sign up |
| Market Cap | $596M |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 0 | 5.8M | -5.8M | -28M | -31M |
| Q2 '23 | 0 | 5.7M | -5.7M | -25M | -28M |
| Q1 '23 | 0 | 5.6M | -5.6M | -29M | -30M |
| Q4 '22 | 0 | 5.7M | -5.7M | -25M | -26M |
| Q3 '22 | 165M | 5.2M | -5.2M | -23M | -23M |
Insider Transactions
| A2A Pharmaceuticals, Inc. filed to sell 3,500,000 shares at $34.6. June 2 '23 |
| A2A Pharmaceuticals, Inc. filed to sell 3,625,000 shares at $33.8. May 17 '23 |
| A2A Pharmaceuticals, Inc. filed to sell 3,650,000 shares at $34.5. May 10 '23 |
| A2A Pharmaceuticals, Inc. filed to sell 3,900,000 shares at $29.1. April 26 '23 |
| A2A Pharmaceuticals, Inc. filed to sell 4,100,000 shares at $31.3. April 6 '23 |
Read more about Biomea Fusion and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, google adspend, google trends, linkedin employees, patents, 4chan mentions, facebook engagement, facebook followers, stocktwits mentions, stocktwits subscribers, twitter followers, youtube subscribers, instagram followers, news mentions, reddit mentions, business outlook.